Top

Published in:

01-04-2001

Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)

Authors: Peter Büchler, M.D., Howard A. Reber, M.D., Manuela C. Bückler, Mendel A. Roth, M.D., Markus W. Büchler, M.D., Helmut Friess, M.D., William H. Isacoff, M.D., Oscar J. Hines, M.D.

Published in: Journal of Gastrointestinal Surgery | Issue 2/2001

Title: Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)
Authors: Peter Büchler, M.D.
Howard A. Reber, M.D.
Manuela C. Bückler
Mendel A. Roth, M.D.
Markus W. Büchler, M.D.
Helmut Friess, M.D.
William H. Isacoff, M.D.
Oscar J. Hines, M.D.
Publication date: 01-04-2001
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 2/2001
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1016/S1091-255X(01)80025-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2001

Upregulation of ornithine decarboxylase mrna expression in barrett’s esophagus and barrett’s-associated adenocarcinoma

A decision analysis of the optimal initial approach to achalasia: Laparoscopic heller myotomy with partial fundoplication, thoracoscopic heller myotomy, pneumatic dilatation, or botulinum toxin injection

Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth

Special problems in minimally invasive surgery of the foregut: Part I

Rationale for the combination of cryoablation with surgical resection of hepatic tumors

Fibrin glue for all anal fistulas